CANARY GLOBAL INDUSTRIES PRIVATE LIMITED
Verified Trust Badges3
Profile
About
Canary Cure Therapeutics is a biotech company pioneering dual gene silencing therapies for obesity and metabolic disease. They are revolutionizing healthcare by harnessing the power of cutting-edge RNA therapies to develop and deliver innovative treatments that address the root causes of diseases. They are committed to fostering a culture of scientific excellence and collaboration to create life-changing treatments that are safe, effective, and accessible to all.
Leadership team
Biotechnology pioneer, President & CEO of Canary Cure Therapeutics. 10+ years in biotech, expertise in RNA therapeutics. Filed 20+ patents i…
Expert in global health, advocacy, and business development with 20+ years experience in drug/medical device development. Helped take two co…
Albert Resnick, M.D. Associate Professor at Rockefeller University, heading the Lab of Molecular Metabolism. Investigates adipose biology an…
Clinical pharmacologist and expert in metabolic syndrome and obesity therapeutics. Head of Therapeutic Department of Internal Medicine at Sa…
Assistant Professor at McGill University in Biochemistry and Goodman Cancer Research Centre. His lab explores molecules and metabolic pathwa…
Partner at Ropes & Gray, advises life sciences and biotech clients on strategic transactions. Expertise includes license agreements, collabo…
Locations
Production capability
Trade background
Certifications & compliance
Government trust score
Anchored to live government registries — MCA, GSTN, DGFT, EPFO. No pay-to-play badges. Refreshed weekly.
Partially verified — 7 of 10 criteria met
